國立高雄大學圖資館 |

Language: English

Back

Relationship between R&D and financial performance in Indian pharmaceutical industry

Record Type:	Electronic resources : Monograph/item
Title/Author:	Relationship between R&D and financial performance in Indian pharmaceutical industryby Mithun Nandy.
Author:	Nandy, Mithun.
Published:	Singapore :Springer Singapore :2022.
Description:	xxxi, 202 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	Pharmaceutical industryIndia.
Online resource:	https://doi.org/10.1007/978-981-16-6921-7
ISBN:	9789811669217$q(electronic bk.)

Relationship between R&D and financial performance in Indian pharmaceutical industry
Nandy, Mithun.

Relationship between R&D and financial performance in Indian pharmaceutical industry[electronic resource] /by Mithun Nandy. - Singapore :Springer Singapore :2022. - xxxi, 202 p. :ill., digital ;24 cm.

Chapter 1. Introduction -- Chapter 2. A Profile of the Indian Pharmaceutical Companies -- Chapter 3. Marketing Activities of Indian Pharmaceutical Companies -- Chapter 4. Research and Development Activities of the Indian Pharmaceutical Companies -- Chapter 5. Global Competitiveness of Indian Pharmaceutical Companies -- Chapter 6. Evaluation of Financial Performance in the Global Context -- Chapter 7. Empirical Study.

The book provides insight into different research and development (R&D) activities performed by Indian pharmaceutical companies. It describes how R&D activities have evolved in the last three decades on Indian soil. The book discusses how emerging economy like India has become the 'Pharmacy of the World' and how reputed and research-centric Indian drug manufacturing companies are aligning their business model by incepting the business idea as 'Innovate in India and Serve to the World'. Subsequently, through successful implementation of the R&D activities and endeavors, Indian pharmaceutical companies have been witnessing different drug discoveries and innovations which have been performed in an indigenous manner. Contemporary marketing strategies adopted by the research-centric Indian pharmaceutical companies for selling innovative drug products across the globe, attaining global competitiveness, and maintaining a seamless supply chain through export initiatives have also been discussed in this book. Finally, the book figures out the relationship between R&D and financial performance with the help of panel data analysis (PDA), an econometric approach. Dr. Mithun Nandy has over 16 years of pharmaceutical industry experience and is currently designated as Assistant General Sales Manager in Hegde & Hegde Pharmaceutica LLP, Mumbai, India. He is responsible for the different domestic and international market operations at H&H which are connected to pharmaceutical product promotion and selling. He has presented numerous research papers and posters at different national and international management conferences. He has a good number of empirical research papers published in various reputable peer-reviewed international journals. His professional success story has been featured in IQVIA Sales View.

ISBN: 9789811669217$q(electronic bk.)

Standard No.: 10.1007/978-981-16-6921-7doiSubjects--Topical Terms:

619150
Pharmaceutical industry
--India.

LC Class. No.: HD9672.I52 / N35 2022

Dewey Class. No.: 338.4761510954

Relationship between R&D and financial performance in Indian pharmaceutical industry
LDR:03262nmm a2200325 a 4500 001 619127
003 DE-He213
005 20211203223552.0
006 m d
007 cr nn 008maaau
008 221103s2022 si s 0 eng d
020 $a 9789811669217$q(electronic bk.)
020 $a 9789811669200$q(paper)
024 7 $a 10.1007/978-981-16-6921-7 $2 doi
035 $a 978-981-16-6921-7
040 $a GP $c GP
041 0 $a eng
050 4 $a HD9672.I52 $b N35 2022
072 7 $a KC $2 bicssc
072 7 $a BUS000000 $2 bisacsh
072 7 $a KC $2 thema
082 0 4 $a 338.4761510954 $2 23
090 $a HD9672.I52 $b N176 2022
100 1 $a Nandy, Mithun. $3 919250
245 1 0 $a Relationship between R&D and financial performance in Indian pharmaceutical industry $h [electronic resource] / $c by Mithun Nandy.
260 $a Singapore : $b Springer Singapore : $b Imprint: Palgrave Macmillan, $c 2022.
300 $a xxxi, 202 p. : $b ill., digital ; $c 24 cm.
505 0 $a Chapter 1. Introduction -- Chapter 2. A Profile of the Indian Pharmaceutical Companies -- Chapter 3. Marketing Activities of Indian Pharmaceutical Companies -- Chapter 4. Research and Development Activities of the Indian Pharmaceutical Companies -- Chapter 5. Global Competitiveness of Indian Pharmaceutical Companies -- Chapter 6. Evaluation of Financial Performance in the Global Context -- Chapter 7. Empirical Study.
520 $a The book provides insight into different research and development (R&D) activities performed by Indian pharmaceutical companies. It describes how R&D activities have evolved in the last three decades on Indian soil. The book discusses how emerging economy like India has become the 'Pharmacy of the World' and how reputed and research-centric Indian drug manufacturing companies are aligning their business model by incepting the business idea as 'Innovate in India and Serve to the World'. Subsequently, through successful implementation of the R&D activities and endeavors, Indian pharmaceutical companies have been witnessing different drug discoveries and innovations which have been performed in an indigenous manner. Contemporary marketing strategies adopted by the research-centric Indian pharmaceutical companies for selling innovative drug products across the globe, attaining global competitiveness, and maintaining a seamless supply chain through export initiatives have also been discussed in this book. Finally, the book figures out the relationship between R&D and financial performance with the help of panel data analysis (PDA), an econometric approach. Dr. Mithun Nandy has over 16 years of pharmaceutical industry experience and is currently designated as Assistant General Sales Manager in Hegde & Hegde Pharmaceutica LLP, Mumbai, India. He is responsible for the different domestic and international market operations at H&H which are connected to pharmaceutical product promotion and selling. He has presented numerous research papers and posters at different national and international management conferences. He has a good number of empirical research papers published in various reputable peer-reviewed international journals. His professional success story has been featured in IQVIA Sales View.
650 0 $a Pharmaceutical industry $z India. $3 619150
650 0 $a Pharmaceutical industry $z India $x Finance. $3 919251
650 1 4 $a Economics, general. $3 731432
650 2 4 $a Accounting/Auditing. $3 274344
650 2 4 $a Market Research/Competitive Intelligence. $3 731061
650 2 4 $a Asian Business. $3 779856
650 2 4 $a Asian Economics. $3 744612
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-16-6921-7
950 $a Economics and Finance (SpringerNature-41170)